Filer Snapshot

Casdin Capital, LLC

CIK 0001534261. SEC filing timeline plus parsed ownership intelligence from 13F, 13D/G, and Forms 3/4/5 where available.

Entity Type

Company

Total Filings

209

Latest Filing

22 May 2026

Industry

n/a

Filing-backed research brief

Start with the SEC data that changes for this CIK

Latest signal: 13F-HR for Q1 2026. Each card links back to the PortfolioSavvy page where the filing evidence is closest.

Largest parsed holding

RVMD

$250.65M reported value

Open holding

13D/G large stake

BLFS

20 May 2026 · 9.7% ownership

Open 13D/G

Save this filer page

Create a free account to keep this page in your watchlists. After verification, we will save it automatically and open your saved research list.

Source: SEC Schedule 13D/G

SCHEDULE 13D/A filed on 22 May 2026 for CIK 0001534261.

View Source Filing
Identity
Business address
1350 Avenue Of The Americas, Suite 2600, New York, NY, 10019
SEC ownership signals
Filing-backed coverage

13F portfolio value

$1.32B

Latest parsed institutional portfolio value.

Insider holdings value

$280.59M

Parsed Forms 3/4/5 holdings where value can be estimated.

Top 13F symbols

RVMD, WGS, RLAY, BLFS

Symbols from the latest parsed 13F holdings.

Schedule 13D positions
BLFS LAB TNYA
Schedule 13G positions
RLAY CDXS NGNE IPSC
SEC record
State of incorporation
DE
Fiscal year end
31 December

Filer intelligence

What SEC filings say about Casdin Capital, LLC

A compact read of parsed XML filings. 13F, 13D/G, and Forms 3/4/5 are shown separately because they answer different ownership questions.

Quick read

  • Latest parsed 13F shows $1.32B across 40 reported holdings for Q1 2026.
  • Largest parsed 13F holding: RVMD at $250.65M.
  • 5 recent 13D/G stake rows found; top row is BLFS at 9.7% ownership.
  • Forms 3/4/5 show insider context for WGS worth $154.95M.

SEC source mix

Counts show available parsed rows, not one combined ownership total.

XML parsed
13F portfolio 40 rows

Quarterly institutional portfolio holdings.

Open
13D/G stakes 5 rows

Beneficial ownership and large-stake disclosures.

Open
Forms 3/4/5 3 rows

Officer, director, and 10% owner holdings or transactions.

Open

Top parsed 13F holdings

Visual share of the latest parsed 13F portfolio. Values are reported market value, not a recommendation.

Q1 2026 - 15 May 2026

Top 5 concentration

59%

Share of latest parsed 13F value represented by the visible holdings below.

Top 5 reported value

$782.51M

Compared with $1.32B total 13F value.

Top 5 net change

+$14.08M

Position-value change inside the visible top holdings only.

13F concentration map

A simple visual split of the latest parsed 13F portfolio.

Largest add: TXG · Largest trim: RNA

RVMD WGS RLAY BLFS LAB Other holdings

RVMD

19%

Revolution Medicines Inc

$250.65M

WGS

14.6%

Genedx Holdings Corp

$193.12M

RLAY

10.9%

Relay Therapeutics Inc

$143.46M

BLFS

8.6%

Biolife Solutions Inc

$113.66M

LAB

6.2%

Standard Biotools Inc

$81.62M

13D/G large-stake context

BLFS

20 May 2026 · Common Stock, par value $0.001 per share

9.7%

RLAY

31 Dec 2025 · Common Stock, par value $0.001 per share

7.5%

LAB

25 Nov 2025 · Common Stock, $0.001 par value per share

24%

CDXS

30 Sep 2025 · Common Stock, par value $0.0001 per share

0%

Forms 3/4/5 insider context

WGS

18 May 2026 · 10% owner

$154.95M

BLFS

19 May 2026 · 10% owner

$112.74M

TSVT

13 May 2025

$12.89M

Latest update

What changed recently for Casdin Capital, LLC

New filing available

Latest Schedule 13D/G period: 20 May 2026. Open the source-backed page to inspect the fresh filing or facts context.

Update date

22 May 2026

Page type

Filer profile

Latest period

20 May 2026

Schedule 13D/G context is visible from filings filed on 22 May 2026.

Benchmark Context

Benchmark context for this company

Casdin Capital, LLC has a source-backed company facts view where you can compare the latest reported metrics with its own recent history and with peer rankings for the same metric.

Compared with

Start on the facts page for period-to-period context, then open a metric ranking when you want to compare the same reported fact across other SEC-reporting companies.

Why this is notable

Latest Schedule 13D/G period: 20 May 2026. That gives you a fresh baseline before you compare this company with peers.

  • Peer comparisons stay conservative: same metric, compatible units, latest valid company row only.
  • Open the facts page first if you want the cleanest path to verification.

Benchmark context is only shown where the app has enough comparable SEC-backed data to keep the interpretation honest.

SEC filing record

CIK 0001534261 filing coverage

Start with this filing record, then use the linked ownership pages when parsed 13F, 13D/G, Forms 3/4/5, or facts data exists for this CIK.

SEC filings
209
First seen
08 Feb 2016
Latest filing
22 May 2026
Entity
Company

Observed form types

SCHEDULE 13D/A 4 13F-HR SCHEDULE 13G/A N-PX 4/A SC 13G SC 13G/A 13F-HR/A SC 13D/A +2 more

Latest Filings

Showing the latest 12 of 209 SEC filings for Casdin Capital, LLC.

SCHEDULE 13D/A

SCHEDULE 13D/A filing

Filing date
22 May 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 001-36362

4 filing

Filing date
21 May 2026
Reporting date
19 May 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 001-39482

4 filing

Filing date
20 May 2026
Reporting date
18 May 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
13F-HR File 028-17113

13F-HR filing

Filing date
15 May 2026
Reporting date
31 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 001-39482

4 filing

Filing date
11 May 2026
Reporting date
07 May 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A

SCHEDULE 13G/A filing

Filing date
17 Feb 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A

SCHEDULE 13G/A filing

Filing date
17 Feb 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
13F-HR File 028-17113

13F-HR filing

Filing date
17 Feb 2026
Reporting date
31 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 001-34180

4 filing

Filing date
04 Dec 2025
Reporting date
02 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13D/A

SCHEDULE 13D/A filing

Filing date
28 Nov 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 001-34180

4 filing

Filing date
26 Nov 2025
Reporting date
24 Nov 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 001-34180

4 filing

Filing date
20 Nov 2025
Reporting date
18 Nov 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .